Investment
Features
FeesSafety
Academy
More
Pluang+

Avalon's Nechalacho Rare Earths Project featured at Canada Investment Summit as key critical minerals opportunity

Market News
15 Sep 2026
Newsfile Corp
View Source
Bullish
Avalon's Nechalacho Rare Earths Project featured at Canada Investment Summit as key critical minerals opportunity

Avalon Advanced Materials' Nechalacho Rare Earths Project in Northwest Territories has been selected for the Canada Investment Summit Prospectus, highlighting it as a strategic critical minerals development opportunity. The project gains exposure to global investors amid growing government focus on secure critical minerals supply chains in North America. Nechalacho is one of Canada's most advanced rare earth assets, with updated technical studies supporting Avalon's plans for development, partnerships, and financing. This inclusion positions the project as a key player in Canada's and North America's critical minerals industry growth.

The Nechalacho Rare Earths Project is highlighted in the Canada Investment Summit Prospectus. For readers following Basic Materials, here is Pluang's market snapshot as of Sep 16, 2026 03:11 WIB: of 32 priced Basic Materials-sector US stocks tradable on Pluang, 7 rose and 25 fell today. Notable price changes include GFI (Gold Fields Limited) at USD 43.00, down 4.66%, SBSW (Sibanye Stillwater Ltd) at USD 11.99, down 4.39%, and LYB (LyondellBasell Industries NV) at USD 65.38, up 4.17%.

More News

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...

Market News
Bullish
40 minutes ago
BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...

Market News
Neutral
1 hour ago
FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...

Market News
Bullish
1 hour ago
K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision has completed over 5,000 procedures using the Light Adjustable Lens (LAL), making it the highest-volume practice worldwide for this technology. The LAL is unique because it can be adjusted after implantation to fine-tune vision based on the...

Market News
Bullish
1 hour ago
BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock, Inc. disclosed that its shareholding in Fagron NV dropped below the 3% threshold to 2.96% after selling some voting securities, despite acquiring equivalent financial instruments. As of October 12, 2026, BlackRock holds 2,015,779 voting ri...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App